Intrinsic Value of S&P & Nasdaq Contact Us

UFP Technologies, Inc. UFPT NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
78/100
5/7 Pass
SharesGrow Intrinsic Value
$257.63
+31.4%
Analyst Price Target
$298.00
+52%

UFP Technologies, Inc. (UFPT) is a Medical - Devices company in the Healthcare sector, currently trading at $196.03. It has a SharesGrow Score of 78/100, indicating a strong investment profile with 5 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of UFPT = $257.63 (+31.4% from the current price, the stock appears undervalued). Analyst consensus target is UFPT = $298 (+52% upside).

Valuation: UFPT trades at a trailing Price-to-Earnings (P/E) of 22.4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.81.

Financials: revenue is $603M, +19.6%/yr average growth. Net income is $68M, growing at +18.2%/yr. Net profit margin is 11.3% (healthy). Gross margin is 28.3% (+2.8 pp trend).

Balance sheet: total debt is $154M against $424M equity (Debt-to-Equity (D/E) ratio 0.36, conservative). Current ratio is 2.68 (strong liquidity). Debt-to-assets is 23.2%. Total assets: $666M.

Analyst outlook: 2 / 2 analysts rate UFPT as buy (100%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value 61/100 (Pass), Growth 80/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 49/100 (Partial), Future 100/100 (Pass), Income 55/100 (Partial).

$298.00
▲ 52.02% Upside
Average Price Target
Based on 2 Wall Street analysts offering 12-month price targets for UFP Technologies, Inc., the average price target is $298.00, with a high forecast of $344.00, and a low forecast of $252.00.
Highest Price Target
$344.00
Average Price Target
$298.00
Lowest Price Target
$252.00

UFPT SharesGrow Score Overview

78/100
SharesGrow Score
Strong investment profile
View full scorecard →
VALUE 61/100
Valuation — P/E, PEG, Forward PEG
GROWTH 80/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 49/100
Gross margin is + market cap
FUTURE 100/100
Analyst outlook — as buy
INCOME 55/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — UFPT

VALUE Pass
61/100
UFPT trades at a trailing Price-to-Earnings (P/E) of 22.4 (S&P 500 average ~25). Forward PEG 1.81 — overvalued. Trailing PEG 13. Analyst consensus target is $298, implying +52% from the current price $196. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
80/100
UFPT: +19.6%/yr revenue is, +18.2%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Pass
100/100
UFPT: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
HEALTH Pass
100/100
Balance sheet UFPT: Debt-to-Equity (D/E) ratio 0.36 (conservative), Current ratio is 2.68 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
49/100
UFPT: Gross margin is 28.3% (+2.8 pp trend), $2B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 49/100. ≥ 70 = Pass.
View details →
FUTURE Pass
100/100
Analyst outlook: 2 / 2 analysts rate UFPT as buy (100%). Analyst consensus target is $298 (+52% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
~
INCOME Partial
55/100
UFPT: Net profit margin is 11.3%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range178.26-274.93
Volume174.4K
Avg Volume (30D)197.33K
Market Cap$1.51B
Beta (1Y)1.17
Share Statistics
EPS (TTM)8.87
Shares Outstanding$7.71M
IPO Date1993-12-17
Employees4,146
CEOR. Jeffrey Bailly
Financial Highlights & Ratios
Revenue (TTM)$602.8M
Gross Profit$170.41M
EBITDA$115.74M
Net Income$68.31M
Operating Income$92.34M
Total Cash$20.3M
Total Debt$154.48M
Net Debt$134.18M
Total Assets$665.74M
Price / Earnings (P/E)22.1
Price / Sales (P/S)2.51
Analyst Forecast
1Y Price Target$298.00
Target High$344.00
Target Low$252.00
Upside+52.0%
Rating ConsensusBuy
Analysts Covering2
Buy 100% Hold 0% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS9026731029

Price Chart

UFPT
UFP Technologies, Inc.  ·  NASDAQ Capital Marke
Healthcare • Medical - Devices
178.26 52WK RANGE 274.93
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message